Risk Score Model for Predicting Mortality in Advanced Heart Failure Patients Followed in a Heart Failure Clinic

Congestive Heart Failure

Volumn 18, Issue 5, 2012, Pages 254-261

  Zafrir, Barak ^a   Goren, Yaron ^b   Paz, Hagar ^c   Wolff, Rafael ^a,c   Salman, Nabia ^a,c   Merhavi, Dina ^a,c   Lavi, Idit ^d   Lewis, Basil S ^a   Amir, Offer ^a,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Lin Medical Center   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERURICEMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QT PROLONGATION; RISK ASSESSMENT; RISK SCORE MODEL; SEX DIFFERENCE; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; CARDIAC CARE FACILITIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; ISRAEL; KAPLAN-MEIER ESTIMATE; MALE; MODELS, THEORETICAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS AS TOPIC;

EID: 84866538195     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2012.00286.x     Document Type: Article

References (34)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2008;29:2388-2442.
2. Amir O, Paz H, Ammar R, et al. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center. Isr Med Assoc J. 2008;10:109-112.
3. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-2667.
4. Lund LH, Aaronson KD, Mancini DM. Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. Am J Cardiol. 2003;92:1350-1354.
5. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure. Derivation and validation of a clinical model. JAMA. 2003;290:2581-2587.
6. Pocock SJ, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65-75.
7. Fonarrow GC, Adams KF, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA. 2005;293:572-580.
8. Brophy JM, Dagenais GR, McSherry F, et al. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med. 2004;116:300-304.
9. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model. Prediction of survival in heart failure. Circulation. 2006;113:1424-1433.
10. May HT, Horne BD, Levy WC, et al. Validation of the Seattle Heart Failure Model in a community based heart failure population and enhancement by adding B-type natriuretic peptide. Am J Cardiol. 2007;100:697-700.
11. Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure. J Am Coll Cardiol. 2008;52:34-56.
12. Vazquez R, Bayes-Genis A, Cygankiewicz I, et al. The MUSIC risk score. A simple method to predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J. 2009;30:1088-1096.
13. Rhode LE, Goldraich L, Polanczyk CA, et al. A simple clinically based predictive rule for heart failure in-hospital mortality. J Card Fail. 2006;12:587-593.
14. Goldraich L, Beck-da-Silva L, Clausell N. Are scores useful in advanced heart failure? Expert Rev Cardiovasc Ther. 2009;7:985-997.
15. Acuna E, Rodriguez C. The treatment of missing values and its effect on the classifier accuracy. In: Banks D, House L, McMorris FR, Arabie P, Gaul W, eds. Classification, Clustering, and Data Mining Applications. Springer: Berlin; 2004;639-647.
16. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
17. Lee TT, Chen J, Cohen DJ, Tsao L. The association between blood pressure and mortality in patients with heart failure. Am Heart J. 2006;151:76-83.
18. Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic function in the digitalis investigation group trial. J Am Coll Cardiol. 2004;44:1025-1029.
19. Roul G, Germain P, Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J. 1998;136:449-457.
20. Shah MR, Hasselblad V, Gheorghiade M, et al. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol. 2001;88:987-993.
21. Wang NC, Maggioni AP, Konstam MA, et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA. 2008;299:2656-2666.
22. Tabrizi F, Englund A, Rosenqvist M, et al. Influence of left bundle branch block on long term mortality in a population with heart failure. Eur Heart J. 2007;28:2449-2455.
23. Gheorghiade M, Rossi JS, Cotts W, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007;167:1998-2005.
24. Doehner W, Landmesser U. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Semin Nephrol. 2011;31:433-440.
25. Bergamini C, Cicoira M, Rossi A, Vassanelli C. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail. 2009;11:444-452.
26. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. Circulation. 2003;107:1991-1997.
27. Klapholz M. Beta-blocker use for the stages of heart failure. Mayo Clin Proc. 2009;84:718-729.
28. O'Connor CM, Hasselblad V, Mehta RH, et al. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol. 2010;55:872-878.
29. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317-327.
30. Zafrir B, Paz H, Wolff R, et al. Mortality rates and modes of death in heart failure patients with reduced versus preserved systolic function. Eur J Intern Med. 2011;22:53-56.
31. Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156:13-22.
32. Blum A, Sirchan R, Abu-Shkara F, Keinan-Boker L. Abdominal circumference and recurrent hospitalizations may affect the clinical outcome of patients with acute heart failure. Exp Clin Cardiol. 2011;16:40-42.
33. Fonarrow GC. Epidemiology and risk stratification in acute heart failure. Am Heart J. 2008;155:200-207.
34. Goldberg LR, Jessup M. Time to be born and a time to die. Circulation. 2007;116:360-362.